Invea Therapeutics, Inc. (INAI)

Invea Therapeutics was planning to go public, but the IPO was withdrawn on Mar 29, 2024.

IPO Price Range

$10.00 - $12.00

Shares Offered

3,200,000

Deal Size

$35.20M

Invea Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Selling, General & Admin	-	2.26	1.1
Research & Development	-	3.45	2.51
Operating Expenses	-	5.7	3.62
Operating Income	-7.1	-5.7	-3.62
Interest Expense (Income)	0.08	0.05	-
Pretax Income	-8.05	-5.75	-3.62
Net Income	-8.05	-5.75	-3.62
Free Cash Flow	-5.27	-5.26	-3.1
EBITDA	-7.96	-5.7	-3.62
Depreciation & Amortization	0	0	-
EBIT	-7.96	-5.7	-3.62

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).